| Ytd | -44.33% | |
| 1y | -79.68% |
| Open | 1.14 | Prev Close | 1.13 | Low | 1.13 | High | 1.14 | Mkt Cap | 911.40K |
| Vol | 554.00 | Avg Vol | 106.03K | EPS | -6.86 | P/E | -0.16 | Forward P/E | -0.65 |
| Beta | 2.54 | Short Ratio | 0.34 | Inst. Own | 1.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.49 | 200-d Avg | 2.59 | 1yr Est | 3.40 |
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP, SXTPW))) ("60 Degrees" or the "Company
https://x.com/PatentGrants/status/2081831140466569485 https://patentcenter.uspto.gov/applications/18
License expands collaboration with Florida State University to evaluate castanospermine for Powassan
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP, SXTPW))) ("60 Degrees Pharma" or the "Com
License allows the Company to commence large-scale extraction of castanospermine from the seeds of C
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001946563/000121390026064796/ea0293532-8k_60degrees
Ascendiant Capital analyst Lucas Ward maintains 60 Degrees (NASDAQ:SXTP) with a Buy and lowers th
60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(1.28) per share which missed the analyst con
During the session on Thursday, 461 stocks hit new 52-week lows.
During Tuesday's session, 275 companies made new 52-week lows.
Friday's session saw 225 companies set new 52-week lows.
Wednesday saw 59 companies set new 52-week lows.
Gainers